Speech-Language Pathologists in Turlock, CA Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Kaci Mead, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 526 Mitchell Ave, Turlock, CA 95380 Phone: 209-605-8126

Tiffany Rachelle Fisher, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3025 W Christoffersen Pkwy Apt D206, Turlock, CA 95382 Phone: 209-568-6186

Anika Dubois Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1801 N Olive Ave, Turlock, CA 95382 Phone: 209-410-7200

Dalia Rasho Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1221 Akron Dr, Turlock, CA 95382 Phone: 209-277-9133

Leslie Lynn Bank Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1801 N Olive Ave, Turlock, CA 95382 Phone: 209-410-7200

Talkin' Tots Speech & Language Therapy, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1670 Fulkerth Rd, Turlock, CA 95380 Phone: 209-226-1409    Fax: 209-226-1410

Elia Ruwe, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3647 Jorge Ct, Turlock, CA 95382 Phone: 510-409-3710

News Archive

Data from Israel's vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response

A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.

BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD

BioSante Pharmaceuticals, Inc., announced today that the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous efficacy data, consultation with key opinion leaders (KOLs) in female sexual dysfunction, testosterone therapy and placebo effects, as well as a meeting with the U.S. Food and Drug Administration (FDA).

Researchers are exploring how healthy people who hear voices can help schizophrenics

How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen. Researchers from the Bergen fMRI Group at the University of Bergen (UiB) are working on how to help schizophrenics, who hear voices. The way they do this is by studying people who also hear voices, but who do not suffer from a mental illness.

Health care providers should assist patients in breaking the smoking habit

More than a quarter of cancer survivors who still smoke have not been advised to quit smoking by their health care providers in the last year, according to a study published by researchers at Fox Chase Cancer Center in the current issue of the Journal of General Internal Medicine.

NxStage Medical signs 5-year distribution agreement with Spindial

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced that it signed a five-year distribution agreement with Spindial S.p.A., a distributor of renal care products, for the promotion, sale, delivery and service of the NxStage System One™ and certain of the Company's in-center products in Italy.

Read more Medical News

› Verified 6 days ago